Advanced Biomed Inc. 8-K

What Happened
Advanced Biomed Inc. announced it delivered a written notice on July 14, 2026 terminating its Purchase Agreement with Helena Global Investment Opportunities I Ltd., under which the company could have issued up to $25,000,000 of common stock. The Purchase Agreement was originally entered on June 6, 2025; termination is effective after five trading days on July 21, 2026. The company states there were no outstanding Advance Notices and it has paid all amounts owed under the agreement, including the Commitment Fee Shares.

Key Details

• Purchase Agreement date: June 6, 2025; investor: Helena Global Investment Opportunities I Ltd.
• Maximum issuance under the agreement: up to $25,000,000 of common stock.
• Termination notice delivered: July 14, 2026; termination effective: July 21, 2026 (per Section 11.02(b)).
• No shares were issued or sold under any Advance other than the Commitment Fee Shares; all amounts owed to the investor have been paid.

Why It Matters
This ends a standing equity financing option that could have allowed Advanced Biomed to raise up to $25M by issuing common stock. For investors, that means one potential source of capital and associated dilution is no longer available, but also that there are no outstanding obligations or pending share issuances under this agreement. The filing does not disclose other financing arrangements or financial impacts beyond confirming payment of fees and the lack of outstanding advances.